IRULYA
Live / Allowed — Publication / registration review complete (as of 10 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Jul 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99933768
- Mark type
- Word mark
- Filed
- 10 Jul 2026
- Published for opposition
- 01 Dec 2026
- Attorney of record
- Amanda H. Wilcox
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of pulmonary, oncology, and neurology diseases and disorders; drug delivery agents in the form of tablets, capsules, oral dissolving tablets, oral disintegrating tablets, injectables, inhalation or nasal formulations, and associated drug-device combinations thereof that facilitate the delivery of pharmaceutical preparations; Inhalers filled with pharmaceutical preparations for the treatment of pulmonary diseases; syringes sold filled with pulmonary, oncology, and neurology pharmaceuticals
- Class 010 — Medical apparatus: Drug delivery devices sold empty, namely, dry powder inhalers, metered dose inhalers, Nebulizers, and Soft mist devices, and structural and replacement parts and components therefor; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Instruments and apparatus provided empty used for the inhalation of pharmaceuticals; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of pulmonary diseases; Nebulizers for medical purposes; Disposable syringes; medical syringes; Syringes for medical purposes and for injections; Syringes for injections; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for the treatment of respiratory conditions
- Class 042 — Scientific and technological services: Medical research; pharmaceutical research and development; scientific research and development; medical and scientific research in the field of pulmonary, oncology, and neurology diseases and disorders; testing of pharmaceuticals; pharmaceutical products development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; medical and scientific research in the field of pharmaceuticals; Laboratory research in the field of pharmaceuticals; Product design and development in the field of dry powder inhaler devices and drug delivery systems; providing medical research information in the field of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: Providing medical information; medical services; providing medical information in the field of pulmonary, oncology, and neurology diseases and disorders; providing medical information, consultancy and advisory services
Owner
- Orphai Therapeutics, LLC, New Haven, CT, US
Prosecution history
- 30 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Oct 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Oct 2026 — EXAMINER'S AMENDMENT ENTERED
- 30 Oct 2026 — EXAMINERS AMENDMENT E-MAILED
- 30 Oct 2026 — EXAMINERS AMENDMENT -WRITTEN
- 27 Oct 2026 — ASSIGNED TO EXAMINER
- 27 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Jul 2026 — APPLICATION FILING RECEIPT MAILED
- 10 Jul 2026 — NEW APPLICATION ENTERED